Government ❯ Regulation

Pharmaceutical Regulation

Drug Approval Drug Safety Quality Control Drug Approval Process NPPA Drug Enforcement Drug Quality Control Drug Control ANMAT Oversight Health Regulations Licensing Drug Manufacturing Oversight Accountability Drug Testing Health Oversight Public Health Drug Safety Oversight Price Control Public Health Policy Domestic Manufacturing Export Standards Safety Inspections Good Manufacturing Practices Safety Standards Drug Pricing Drug Manufacturing EU Commission Clinical Trials Vaccine Regulation FDA Drug Control Administration Controlled Substances Legal Framework Health Policy European Medicines Agency Consumer Protection Health Authorities Chemical Precursor Regulation

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs

The move advances onshoring of active ingredients to support orforglipron within Lilly’s $27 billion U.S. buildout.